Assessing causality by means of the Naranjo scale in a paediatric patient with life threatening respiratory failure after alemtuzumab administration: a case report
Abstract Background Alemtuzumab is a T cell depleting antibody agent used as induction immunosuppressant therapy in solid organ transplant recipients. In addition, it is being increasingly used to treat severe or glucocorticoid-resistant graft rejection. Despite the effectiveness of the treatment, s...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2021-05-01
|
| Serie: | BMC Pediatrics |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12887-021-02698-w |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
